Medical Treatment for Scars & Keloids | NYU Langone Health
NYU Langone dermatologists recommend laser treatments, steroid injections, radiotherapy, and dermabrasion to improve the appearance of scars.
A SINGLE CENTER PILOT STUDY ESTABLISHING TEST-RETEST RELIABILITY OF SWALLOWING PRESSURES COLLECTED WITH HIGH RESOLUTION PHARYNGEAL MANOMETRY (HRPM)
Difficulty swallowing (known as dysphagia) can have devastating consequences for health and quality of life. The current gold-standard assessment tool, videofluoroscopy (VF), allows real time visualization of swallowing via a video x-ray. Unfortunately, VF exposes the patient to radiation and therefore is limited in its use. A relatively new technique for quantifying swallowing physiology is called High Resolution Pharyngeal Manometry (HRPM) - it registers the pressures generated by the swallowing muscles on a catheter passed through the nose to the esophagus. Our team (speech pathology, otolaryngology, gastroenterology) recently acquired an HRPM system and is eager to employ it in our research grants with a focus on aging, disease progression, and treatment for swallowing disorders. However, at this time, very little is known about the test-retest reliability of this tool which leaves us unable to conduct realistic power calculations in these proposals. Therefore, we will plan to collect VF/HRPM test-retest data in 20 older adults two weeks apart.
community-report.pdf
... of health and housing. The lab focuses on the following key activities and focus areas: • Conducting ... priorities, the NYU Langone Hospitals three-year implementation plan (the Community Service Plan) focuses ...
Diagnosing Vertigo | NYU Langone Health
Doctors at NYU Langone perform a variety of hearing, sensory, and imaging tests to diagnose vertigo.
Group Psychotherapy | NYU Langone Health
Specialists at NYU Langone Psychiatry Associates offer group psychotherapy to help facilitate personal growth and healing.
Diagnostic and Treatment Options for GERD and Bronchiectasis
... be treated, with a focus on a long-term approach? – How should we follow our treatment of the esophageal ...
community-health-executive-summary-english-11.22.pdf
... with a variety of health concerns. As with our previous Community Service Plan, the 2022-2024 Plan focuses ... program, using an evidence-based youth leadership and peer education model. Particular focus ...
Investigation of cellular and molecular interactions in inflammation angiogenesis and immunity in human atherosclerosis: the ATHERO-IN study
Atherosclerotic cardiovascular disease (ACVD) is driven by inflammation and is the leading cause of mortality and disability worldwide, even in optimally treated patients. The impact of many immune cells (inflammatory cells) on atherosclerosis progression is well-established, the contribution of different immune and non-immune cells to human disease pathology and cardiovascular (CV) events remain largely unknown. It is well established that specific histological features of plaque instability are associated with increased risk for cardiovascular events (i.e. stroke, heart attack). This study will address the following knowledge gaps. The ATHERO-IN study is a prospective and retrospective, multisite, observational study. The study will be conducted at two study sites: 1. the NYU Langone Health (coordinating and recruitment site) and 2. the Icahn School of Medicine at Mount Sinai (recruitment site). The Focus of the study is atherosclerotic cardiovascular disease and inflammation. The Goal of the study is to identify new cellular and molecular determinant of atherosclerosis, plaque pathology and cardiovascular events. To achieve this goal, we will use a system biology approach to analyze human samples that will be obtained from patients with atherosclerotic cardiovascular disease from the NYU Langone Health System (NYULH) and from the Mount Sinai Health System (MSHS).
Community Events at NYU Langone Hospital—Long Island | NYU Langone Health
NYU Langone Hospital—Long Island provides educational lectures, parent education classes, and support groups for the Long Island community.
A Phase 1 Trial Investigating LY4101174 an Antibody-Drug Conjugate Targeting Nectin-4 in Participants with Recurrent Advanced or Metastatic Solid Tumors
This is a study looking at a new medicine called LY4101174. The study team wants to see if it has few effects and how well it works in treating the cancer in patients with advanced or metastatic cancers, including urothelial carcinoma. The study has two parts. In the first part, the study team will test different amounts of LY4101174 to find the dose with the fewest side effects for the next part of the study. The study team will also check if there is a need to adjust the dose based on side effects if there are any. The second part will involve more patients, and they will use the best dose with few side effects found in the first part. The study will focus on different types of cancers like breast, lung, ovarian, and other cancers. The study team wants to understand how this medicine works and if it helps patients with treating these cancers.